Proteomics International Laboratories Set to Start National Rollout of Two Blood Tests

MT Newswires Live10-23 14:12

Proteomics International Laboratories' (ASX:PIQ) national rollout of Promarker D and Promarker Eso blood tests is due to start on Oct. 26 in collaboration with Australian pathology distribution partner Healius (ASX:HLS), according to a Friday filing with the Australian bourse.

Field sales teams have completed training in both tests, which are designed to assess the risk of specific chronic diseases.

Proteomics and Healius have also agreed on joint sales and marketing plans to support clinician education, awareness, and appropriate referrals.

The national rollout of the two tests will support the commercial release of the PromarkerEndo blood test planned for the third quarter of fiscal 2027, Proteomics International said.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment